APA (7th ed.) Citation

E, V., JL, F. C., NM, P. F., CH, C., MR, T. G., CS, N., & FD, C. (2023). Intraosseous Spindle Cell/Epithelioid Rhabdomyosarcoma with TFCP2 Rearrangement: A Recent Recognized Subtype with Partial Response to Alectinib. International journal of surgical pathology, 31(5), 861. https://doi.org/10.1177/10668969221140397

Chicago Style (17th ed.) Citation

E, Valério, Furtado Costa JL, Perez Fraile NM, Credidio CH, Taveira Garcia MR, Neto CS, and Costa FD. "Intraosseous Spindle Cell/Epithelioid Rhabdomyosarcoma with TFCP2 Rearrangement: A Recent Recognized Subtype with Partial Response to Alectinib." International Journal of Surgical Pathology 31, no. 5 (2023): 861. https://doi.org/10.1177/10668969221140397.

MLA (9th ed.) Citation

E, Valério, et al. "Intraosseous Spindle Cell/Epithelioid Rhabdomyosarcoma with TFCP2 Rearrangement: A Recent Recognized Subtype with Partial Response to Alectinib." International Journal of Surgical Pathology, vol. 31, no. 5, 2023, p. 861, https://doi.org/10.1177/10668969221140397.